Syschem (India) Ltd. (BSE: 531173) is a Chandigarh-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹186 Cr, it ranks #2,721 by market cap among the 6,137 Indian listed companies on FinBizNet, and #58 of 86 in Medicinal Chemicals and Botanical Products. At ₹31.03 (as of 25 Oct 2026), the share price is 49.1% below its 52-week high of ₹60.95 and 7.7% above its 52-week low of ₹28.81. The share price is down 44.6% over one year and down 26.2% over three months.
| Current Price | ₹31.03 |
|---|---|
| Market Cap | ₹186 Cr |
| BSE Code | 531173 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 18.2 |
| Return on Equity | 10.23% |
| Return on Assets | 4.18% |
| 52-Week Range | ₹28.81 – ₹60.95 |
| 1-Year Price Change | -44.6% |
| 3-Month Price Change | -26.2% |
| Beta (1Y) | 0.53 |
| Headquarters | Chandigarh |
| Website | www.syschem.in |
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
1. Chemicals-This segment manufactures ands sells pharmaceutical products. 2. Pharmaceutical Products-This segment engages in the manufacture and sale of monocorotophons, dichlorovos, pivaloyl chloride, bromine, and other chemicals and intermediates.
1. Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Syschem (India) Ltd. | ₹186 Cr | 18.2 | 10.23% | — | -44.6% |
Listed by market capitalisation. Ratios are shown for context only.
Syschem (India) Ltd. is trading at ₹31.03, with a market capitalisation of ₹186 Cr.
Syschem (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Syschem (India) Ltd. has a P/E of 18.2 and a return on equity of 10.23%.
Syschem (India) Ltd. is listed on the BSE under the scrip code 531173.
Syschem (India) Ltd.'s share price is down 44.6% over one year and down 26.2% over three months. Its 52-week range is ₹28.81 to ₹60.95.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.